<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink="#954F72"><div class=WordSection1><p class=MsoNormal>Hi all:</p><p class=MsoNormal>See below for an interesting article.</p><p class=MsoNormal>Thx.</p><p class=MsoNormal>Glen</p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Sent from <a href="https://go.microsoft.com/fwlink/?LinkId=550986">Mail</a> for Windows 10</p><p class=MsoNormal><o:p> </o:p></p><div style='mso-element:para-border-div;border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal style='border:none;padding:0cm'><b>From: </b><a href="mailto:cancernetwork@email.cmpmedica-usa.com">Cancer Network</a><br><b>Sent: </b>February 8, 2018 10:03 AM<br><br><b>Subject: </b>ASCO GU: Drug Delays Prostate Cancer Metastasis By 2 Years</p></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span style='font-size:1.0pt;display:none'>Docetaxel plus hormone therapy improves QOL in prostate cancer patients<o:p></o:p></span></p><div id=wrapper><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal align=center style='margin-bottom:12.0pt;text-align:center'><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#333333'>To view this email as a web page, click <a href="http://view.email.cmpmedica-usa.com/?qs=536cba43e0bcd6b7cd10f1dadf904cad59048ad89a740d699700fbb2ee29e52c0101c9e2b703638b5bbd1bd2d7598261e35c63d4dfce733a57fcff37fab0edbddd3ce375c2c72bfa4649de2b849d0c15"><b><span style='font-size:8.5pt;color:#056C9C'>here.</span></b></a></span><o:p></o:p></p></td></tr><tr><td style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#333333;border-spacing: 0'><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:#333333;border-collapse:collapse'><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><img border=0 width=220 height=20 style='width:2.2916in;height:.2083in' id="_x0000_i1034" src="http://www.ubmmedica.com/wp-content/uploads/2016/11/ModernMedicineNetwork-small.png" alt="Modern Medicine Network"><o:p></o:p></p></td></tr></table></div></td></tr></table></div><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;border-spacing: 0;min-width: 600px'><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e4ee7fb94c374654f0c4d476dd9bd6582112478bfecd8800aa29e7426e8ae1268d871c1ced01c2a63"><span style='color:#295AA6;text-decoration:none'><img border=0 width=360 height=69 style='width:3.75in;height:.7187in' id="_x0000_i1033" src="http://images.ubmmedica.com/newsletters/Logos/CancerNetworkLogo.png" alt="Cancer Network"></span></a><o:p></o:p></p></td></tr><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><img border=0 width=600 height=120 style='width:6.25in;height:1.25in' id="_x0000_i1032" src="http://content.ubmlifesciences.com/sites/default/files/conference-insider-GU-meeting-NL-banner-2018.jpg" alt="Cancer Network"><o:p></o:p></p></td></tr></table></div><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:#1A357D;border-collapse:collapse;border-spacing: 0;min-width: 600px'><tr><td style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal><span style='font-size:9.0pt;font-family:"Arial",sans-serif;color:white'>ASCO GU 2018 | February 8, 2018 <o:p></o:p></span></p></td></tr></table></div><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;border-spacing: 0;min-width: 600px'><tr style='height:1.5pt'><td style='padding:0cm 0cm 0cm 0cm;height:1.5pt'><p class=MsoNormal> <o:p></o:p></p></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=270 style='width:202.5pt;border-collapse:collapse;border-spacing: 0' id=articles><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e9154b27b3f13f0135592947a947f7a84a909d5596bb223542c5a3f199ddb1d436359f816164d1b38"><b><span style='font-size:12.5pt;font-family:"Arial",sans-serif;color:#056C9C'>Apalutamide Delays Metastasis in Prostate Cancer</span></b></a> <o:p></o:p></p></td></tr><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#333333'>Apalutamide was well-tolerated and associated with delayed metastasis in men with high-risk castration-resistant prostate cancer that has become refractory to conventional hormone therapy, according to an early interim analysis of the phase III SPARTAN clinical trial. <o:p></o:p></span></p></td></tr><tr style='height:1.5pt'><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt;height:1.5pt'><p class=MsoNormal><span style='font-size:12.5pt'><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e9154b27b3f13f0135592947a947f7a84a909d5596bb223542c5a3f199ddb1d436359f816164d1b38"><span style='font-family:"Arial",sans-serif;color:#056C9C'> Read more </span></a></span> <o:p></o:p></p></td></tr></table><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 align=right width=300 style='width:225.0pt;border-collapse:collapse;border:none;margin-top:2.75pt;margin-bottom:2.75pt'><tr><td style='border:none;border-left:solid #F0F1F2 1.5pt;padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal align=center style='text-align:center'><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#333333'>ADVERTISEMENT <o:p></o:p></span></p></td></tr><tr><td style='border:none;border-left:solid #F0F1F2 1.5pt;padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><b><span style='font-size:14.5pt;font-family:"Arial",sans-serif;color:#575452'><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e5179ef80e1d77744b0c8440a50170baf1ec63170f39e00db0c79836a1612ac2b266aa7728807a2fa"></a></span></b><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="advertisement" o:spid="_x0000_s1026" type="#_x0000_t75" alt="Ad/company name goes here" href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e5179ef80e1d77744b0c8440a50170baf1ec63170f39e00db0c79836a1612ac2b266aa7728807a2fa" style='position:absolute;margin-left:173.8pt;margin-top:0;width:225pt;height:187.5pt;z-index:251659264;visibility:visible;mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:right;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:line;mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;mso-height-relative:page' o:allowoverlap="f" o:button="t">
<v:imagedata src="http://oascnx15005.247realmedia.com/RealMedia/ads/adstream_nx.ads/cancernetworkEnews/CN/Econf/02082018/102082018@x30?_RM_NX_ID_=102082018" />
<w:wrap type="square" anchory="line"/>
</v:shape><![endif]--><![if !vml]><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e5179ef80e1d77744b0c8440a50170baf1ec63170f39e00db0c79836a1612ac2b266aa7728807a2fa"><img border=0 width=300 height=250 style='width:3.125in;height:2.6041in' src="http://oascnx15005.247realmedia.com/RealMedia/ads/adstream_nx.ads/cancernetworkEnews/CN/Econf/02082018/102082018@x30?_RM_NX_ID_=102082018" align=right alt="Ad/company name goes here" v:shapes="advertisement"></a><![endif]><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e5179ef80e1d77744b0c8440a50170baf1ec63170f39e00db0c79836a1612ac2b266aa7728807a2fa"><b><span style='font-size:14.5pt;font-family:"Arial",sans-serif;color:#295AA6;text-decoration:none'><img border=0 width=1 height=1 style='width:.0104in;height:.0104in' id="_x0000_i1031" src="https://ad.doubleclick.net/ddm/ad/N6246.131798.CANCERNETWORK/B20577073.213544923;sz=1x1;ord=12345678;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=?" alt="https://ad.doubleclick.net/ddm/ad/N6246.131798.CANCERNETWORK/B20577073.213544923;sz=1x1;ord=12345678;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=?"></span></b></a><b><span style='font-size:14.5pt;font-family:"Arial",sans-serif;color:#575452'><o:p></o:p></span></b></p></td></tr></table></td></tr></table></div><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;border-spacing: 0;min-width: 600px'><tr style='height:1.5pt'><td style='padding:0cm 0cm 0cm 0cm;height:1.5pt'><p class=MsoNormal> <o:p></o:p></p></td></tr><tr><td style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse;border-spacing: 0'><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63ef00f143398795b375cdfa175ef34ae7296c6053f42332700349c1ae14429a13c1136f8e9a1e5fe16"><b><span style='font-size:12.5pt;font-family:"Arial",sans-serif;color:#056C9C'>Docetaxel Plus Hormone Therapy Improves QOL in Prostate Cancer Patients</span></b></a> <o:p></o:p></p></td></tr><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;border-spacing: 0' id=articles><tr><td valign=top style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#333333'>Adding docetaxel chemotherapy to frontline hormone therapy improves quality of life and may reduce the need for subsequent treatment, according to an analysis from the STAMPEDE trial.<br><br></span><span style='font-size:11.5pt;font-family:"Arial",sans-serif;color:#333333'><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63ef00f143398795b375cdfa175ef34ae7296c6053f42332700349c1ae14429a13c1136f8e9a1e5fe16"><span style='color:#056C9C'> Read more </span></a></span><span style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#333333'> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;border-spacing: 0;min-width: 600px'><tr style='height:1.5pt'><td style='padding:0cm 0cm 0cm 0cm;height:1.5pt'><p class=MsoNormal> <o:p></o:p></p></td></tr><tr><td style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse;border-spacing: 0'><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63ee907e149cc55d463f485a075da1045f047a16d8ca8b776898953249717684ad974c38c98789c2636"><b><span style='font-size:12.5pt;font-family:"Arial",sans-serif;color:#056C9C'>First-Line Atezolizumab/Bevacizumab Well-Tolerated in Metastatic RCC</span></b></a> <o:p></o:p></p></td></tr><tr><td style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;border-spacing: 0' id=articles><tr><td valign=top style='padding:3.75pt 3.75pt 3.75pt 3.75pt'><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#333333'>Adding atezolizumab and bevacizumab to standard care was tolerable and slowed tumor growth in patients with previously untreated clear-cell or sarcomatoid-histology metastatic renal cell carcinoma when compared to sunitinib, according to findings from a phase III study.<br><br></span><span style='font-size:11.5pt;font-family:"Arial",sans-serif;color:#333333'><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63ee907e149cc55d463f485a075da1045f047a16d8ca8b776898953249717684ad974c38c98789c2636"><span style='color:#056C9C'> Read more </span></a></span><span style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#333333'> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse;border-spacing: 0;min-width: 600px'><tr style='height:1.5pt'><td style='padding:0cm 0cm 0cm 0cm;height:1.5pt'><p class=MsoNormal> <o:p></o:p></p></td></tr></table></div></td></tr></table><p class=MsoNormal style='background:#F0F1F2'><span style='display:none'><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#323232'><tr><td style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:#323232'><tr><td style='border:none;border-bottom:solid #555555 2.25pt;padding:7.5pt 7.5pt 7.5pt 7.5pt'><p style='line-height:140%'><b><span style='font-size:9.0pt;line-height:140%;font-family:"Arial",sans-serif;color:#888888'>This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.<o:p></o:p></span></b></p></td></tr></table></div></td></tr><tr><td style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:#323232' id=footer><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="27%" style='width:27.0%;background:#323232'><tr><td valign=top style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal><img border=0 width=51 height=74 style='width:.5312in;height:.7708in' id="_x0000_i1030" src="http://images.ubmmedica.com/ubm-logo-newsletter-2017-white.png" alt="http://images.ubmmedica.com/ubm-logo-newsletter-2017-white.png"><o:p></o:p></p><p style='line-height:140%'><span style='font-size:8.5pt;line-height:140%;font-family:"Arial",sans-serif;color:#888888'>This email was sent by: <b>UBM Medica, a division of UBM Americas</b><br>535 Connecticut Avenue, Suite 300<br>Norwalk, CT, 06854, USA<o:p></o:p></span></p></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="27%" style='width:27.0%;background:#323232' id=footer><tr><td valign=top style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p><b><span style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#B2B2B2'>NEWSLETTER<o:p></o:p></span></b></p><p style='line-height:140%'><span style='font-family:"Arial",sans-serif;color:#888888'><a href="http://view.email.cmpmedica-usa.com/ftaf.aspx?qs=536cba43e0bcd6b7cd10f1dadf904cad59048ad89a740d699700fbb2ee29e52cc8009c8b9c41e48c295fc567a7b7e7f1"><span style='font-size:10.0pt;line-height:140%;color:#BEBEBE;text-decoration:none'>Forward to a Friend</span></a></span> <br><span style='font-family:"Arial",sans-serif;color:#888888'><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e5cb0cd04f40efe82a8d8a5659aee6db12c8e518147e76befb5b398a89027a17f28c91cec9fa5700e"><span style='font-size:10.0pt;line-height:140%;color:#BEBEBE;text-decoration:none'>Privacy Statement</span></a></span><br><span style='font-family:"Arial",sans-serif;color:#888888'><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e9c2592be5ef2e263e94e1443eeab2a50db409be185d241637633225eff908365a8bcc1546ec567ed"><span style='font-size:10.0pt;line-height:140%;color:#BEBEBE;text-decoration:none'>Terms of Service</span></a></span><br><span style='font-family:"Arial",sans-serif;color:#888888'><a href="http://click.email.cmpmedica-usa.com/profile_center.aspx?qs=a2b941f134a42763c587af15301dc42e736c79925b42e44811f8b9c9a09c59e178f0122b4e8edf13fd22b5af01bfb15a2997bf57a2d091ee8d3c8f8102795c9b34b9e87c93750b2b"><span style='font-size:10.0pt;line-height:140%;color:#BEBEBE;text-decoration:none'>Update Profile</span></a></span><br><span style='font-family:"Arial",sans-serif;color:#888888'><a href="http://click.email.cmpmedica-usa.com/subscription_center.aspx?qs=a2b941f134a427630194887cedb9930ef75b17e24185ae04028d35d5beb7054bbc4302e2ebd3d63c7e2aee3f096648b228f222e21c983b54621cbec966976f5c5ace7ea83773ac6b"><span style='font-size:10.0pt;line-height:140%;color:#BEBEBE;text-decoration:none'>Add/Remove Newsletters</span></a></span><br><span style='font-family:"Arial",sans-serif;color:#888888'><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e98f947d2669939b24990373374e08c30bd2bc956e308d1de71f4c065598a0de69ff644e0387314b4"><span style='font-size:10.0pt;line-height:140%;color:#BEBEBE;text-decoration:none'>Subscribe to Print</span></a></span><br><span style='font-family:"Arial",sans-serif;color:#888888'><a href="mailto:editorial@hcl.com"><span style='font-size:10.0pt;line-height:140%;color:#BEBEBE;text-decoration:none'>Contact Us</span></a></span> </p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right width="38%" style='width:38.0%;background:#323232'><tr><td valign=top style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p><b><span style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#B2B2B2'>CONNECT<o:p></o:p></span></b></p><p class=MsoNormal><a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63eabbe6e98ac79e0dbb0f19713392f97915df1fb6ec2cd5e1401a6a8f7cf6293865ad3498966b9f097"><span style='color:#295AA6;text-decoration:none'><img border=0 width=35 height=35 style='width:.3645in;height:.3645in' id="_x0000_i1029" src="http://images.ubmmedica.com/newsletters/social_media/twitter_icon.png" alt=Twitter></span></a> <a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63ec27db054d1955f9060ad5cb3b78effe75e57b3a682ea729db6f226dbe2cb7d1f4f168a91950fff7d"><span style='color:#295AA6;text-decoration:none'><img border=0 width=35 height=35 style='width:.3645in;height:.3645in' id="_x0000_i1028" src="http://images.ubmmedica.com/newsletters/social_media/facebook_icon.png" alt=Facebook></span></a> <a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63effdcadfe3b3ab6c05f088c86521fea9077ada10a734966af2a5623653ffa10ef0551a96be502c140"><span style='color:#295AA6;text-decoration:none'><img border=0 width=35 height=35 style='width:.3645in;height:.3645in' id="_x0000_i1027" src="http://images.ubmmedica.com/newsletters/social_media/linkedin_icon.png" alt=LinkedIn></span></a> <a href="http://click.email.cmpmedica-usa.com/?qs=b5713da92c59a63e0e41822e7d5461bf3f52a7d106c72946d550ced87b714a7b294d128769a382ee89a189e4b17ec451"><span style='color:#295AA6;text-decoration:none'><img border=0 width=35 height=35 style='width:.3645in;height:.3645in' id="_x0000_i1026" src="http://images.ubmmedica.com/newsletters/social_media/rss_icon.png" alt=RSS></span></a><o:p></o:p></p></td></tr></table></td></tr></table></div></td></tr><tr style='height:1.5pt'><td style='padding:0cm 0cm 0cm 0cm;height:1.5pt'><p class=MsoNormal><span style='font-size:7.5pt;font-family:"Arial",sans-serif'> <o:p></o:p></span></p></td></tr></table></div></div><p class=MsoNormal><img border=0 width=1 height=1 style='width:.0104in;height:.0104in' id="_x0000_i1025" src="http://click.email.cmpmedica-usa.com/open.aspx?ffcb10-fe571679726d07797710-fdbb1570736204787d10767d6c-feca15707d60027f-fe98157571670c7d77-fdf01575716504757d12757c-ffcf14" alt="http://click.email.cmpmedica-usa.com/open.aspx?ffcb10-fe571679726d07797710-fdbb1570736204787d10767d6c-feca15707d60027f-fe98157571670c7d77-fdf01575716504757d12757c-ffcf14"><o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>